CASC2 and hepatocellular carcinoma: The downregulation of lncRNA cancer susceptibility candidate 2 (CASC2) in HCC tissues and HCC cells and binding of CASC2 to miR-367 to upregulate F-box/WD repeat-containing protein 7 (FBXW7) expression inhibits EMT in HCC [56].